573693-07-9

Basic information

• Product Name: Benzoic acid, 4-methoxy-3-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester
• CAS NO: 573693-07-9
• Molecular Formula: C10H9F3O6S
• Molecular Weight: 314.239
• Mol File: 573693-07-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-methoxy-3-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-methoxy-3-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester(573693-07-9)
• EPA Substance Registry System: Benzoic acid, 4-methoxy-3-[[(trifluoromethyl)sulfonyl]oxy]-, methyl ester(573693-07-9)

Safety Data

• Hazardous Substances Data: 573693-07-9(Hazardous Substances Data)

Upstream product

• 645-08-9 Isovanillic acid 
• 358-23-6 trifluoromethylsulfonic anhydride 
• 6702-50-7 3-hydroxy-4-methoxybenzoate 

Downstream Products

• 573693-12-6 3-(2-bromo-4-methoxy-3-methyl-phenylamino)-4-methoxy-benzoic acid methyl ester 
• 573693-15-9 1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hex-1-enyl)-7-methyl-9H-carbazole-4-carboxylic acid methyl ester 
• 573693-16-0 [1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hex-1-enyl)-7-methyl-9H-carbazol-4-yl]-methanol 
• 573693-14-8 8-bromo-1,6-bis-(tert-butyl-diphenyl-silanyloxy)-7-methyl-9H-carbazole-4-carboxylic acid methyl ester 
• 886036-90-4 1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hept-1-enyl)-7-methyl-9H-carbazole-4-carboxylic acid methyl ester 
• 886036-91-5 [1,6-bis-(tert-butyl-diphenyl-silanyloxy)-8-(2,5-dimethyl-hept-1-enyl)-7-methyl-9H-carbazol-4-yl]-methanol 

Relevant articles and documents

First total synthesis of the neuronal cell protecting carbazole alkaloid carbazomadurin A by sequential transition metal-catalyzed reactions

The highly oxygenated neuronal cell protecting carbazole alkaloid carbazomadurin A was synthesized in nine steps and 11% overall yield from isovanillic acid.

NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE HAVING GLUCOCORTICOID RECEPTOR BINDING ACTIVITY

An object of the present invention is to synthesize a novel 1,2,3,4-tetrahydroquinoxaline derivative represented by formula (1) and to find a pharmacological action of the derivative. In the formula, the R1 represents a halogen, an alkyl, cycloalkyl, aryl or heterocyclic group, or the like; p represents 0 to 5; R2 represents a halogen, an alkyl, hydroxyl or alkoxy group, or the like; q represents 0 to 2; R3 represents hydrogen, an alkyl, alkenyl, alkylcarbonyl or arylcarbonyl group, or the like; R4 and R5 independently represent hydrogen, a halogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; R6 represents hydrogen, an alkyl, alkenyl, alkynyl, cycloalkyl, aryl or heterocyclic group, or the like; A represents an alkylene; R7 represents OR8, NR8R9, SR8, S(O)R8, S(O)2R8; and X represents O or S.